The Might of Molecular
Affordable, Rapid, and Accurate Point-of-Care Diagnostics for Family & Women’s Health
A New Era of Diagnostics for Better Health Outcomes
Fast & Accurate Results*
Less Than One Minute Hands-On Time
Advanced Multiplex Technology**
Test-to-Treat
The DX 100™ Platform
Our innovative diagnostic platform is designed to provide both healthcare professionals and patients with fast, accurate, and reliable results. Experience a new era in diagnostics that prioritizes efficiency, affordability, and accuracy, ensuring you get the answers you need quickly.
*The clinical study for the AmplifiDx COVID-19 Assay™ (Detection of SARS-CoV-2) on the DX 1000 System™ (First-Generation Instrument) resulted in a 97.8% PPA and 100% NPA (Comparator: Roche cobas® liat).
**The DX 100™ Platform can detect up to 10 analytes.
Developing Point-of-Need Molecular Diagnostics
Sexual Health
Family & Women’s Health
Not Cleared or approved by the FDA
About Us
Vision
AmplifiDx envisions a future where advanced diagnostics are accessible worldwide, improving global health outcomes.
Mission
AmplifiDx is combatting the spread of infectious diseases by enabling global access to fast, accurate, and simple point-of-care testing.
Meet the Team
-
Nancy Schoenbrunner
Chief Executive Officer
-
Shoulian Dong
Chief Scientific Officer
-
Daniel Schoener
Chief Product Officer
-
Chris Meda
Chief Commercial Officer
How Did We Get Here?
Bioburst.io
764 Main Street
Waltham, MA 02451